Body Composition (Fat Mass, Lean Mass, Visceral Fat)

Body composition, the proportion and distribution of fat mass, lean muscle mass, and bone mass in the body, provides a far more health-relevant picture than body weight or BMI alone, since two people with identical BMI can have very different metabolic risk depending on how much of that weight is muscle versus visceral fat. The claim: the combination of low muscle mass (sarcopenia) and high visceral or abdominal fat, sometimes called sarcopenic obesity, carries dramatically higher mortality and cardiovascular risk than either condition alone.

A 2025 study of older adults with cardiovascular disease found sarcopenia alone was associated with a 1.93-fold increased risk of the composite primary outcome (95% CI 1.02-3.66), but this risk jumped to 6.74-fold (95% CI 1.81-25.16) in patients with sarcopenic obesity, driven substantially by all-cause mortality that was 8.48 times higher in sarcopenic patients compared with non-sarcopenic patients (56.3 vs. 6.9 deaths per 1,000 person-years) [1]. A Brazilian population-based cohort of community-dwelling older adults found that in men, each 100-gram increase in visceral fat mass raised all-cause mortality odds by 99% (odds ratio 1.99, 95% CI 1.38-2.87) after adjustment for BMI, smoking, and other risk factors, while fat mass index was actually associated with lower mortality risk once sarcopenia and visceral fat were accounted for separately, illustrating that it is fat distribution and lean mass, not total fat mass, that carries the risk signal [2]. In women in the same cohort, sarcopenia alone was an extremely strong predictor of both all-cause (odds ratio 62.88) and cardiovascular mortality (odds ratio 74.54), far exceeding the male-specific effect sizes, indicating substantial sex differences in how body composition translates to mortality risk [2]. An umbrella review of systematic reviews found sarcopenic obesity increased cardiovascular mortality risk (hazard ratio 1.63, 95% CI 1.01-2.62) though the certainty of evidence was rated very low due to inconsistency across studies [3].

How to measure it: dual-energy X-ray absorptiometry (DXA) is the clinical reference standard, providing separate measurements of fat mass, lean mass, and bone mineral density along with regional distribution, though DXA visceral fat estimates are less precise than CT or MRI [4]. Bioelectrical impedance analysis (BIA) offers a cheaper, more accessible but less accurate alternative common in consumer scales and clinics [5].

How to intervene on it: resistance training combined with adequate protein intake is the best-supported intervention for preserving or building lean muscle mass while losing fat, and is specifically recommended over pure caloric restriction alone in older adults, since weight loss without resistance exercise disproportionately reduces muscle mass alongside fat mass, worsening the sarcopenic-obesity risk profile rather than improving it.

Critics note that most body-composition mortality studies are observational and vary widely in sarcopenia and obesity definitions used across studies, contributing to the very-low-certainty grading in systematic review evidence [3]; measurement method also matters substantially, since DXA, BIA, and CT/MRI visceral fat estimates do not always agree closely with each other, complicating comparison across the literature [5].

Bryan Johnson's Blueprint protocol tracks DXA-measured body fat percentage and lean mass as routine panel items, an n=1 self-report rather than trial evidence [6].

The plain takeaway: total body weight and BMI obscure a health-relevant distinction between muscle and fat, and losing muscle while carrying excess visceral fat, sarcopenic obesity, carries dramatically higher mortality risk than either condition in isolation, making resistance training alongside any weight-management effort a priority rather than an optional add-on.